Meningioma is a common intracranial tumor, most of which are benign and only 3-5% of meningiomas are malignant. Surgical resection is the most important treatment procedure for meningioma, and most meningiomas can be cured by surgical resection alone to achieve a more satisfactory treatment effect. However, a small number of meningiomas grow rapidly and are prone to recur years later after surgical resection, even with adjuvant radiation therapy, which is difficult to avoid recurrence. Meningioma recurrence is associated with a variety of factors, both on the tumor itself and treatment-related factors. The recurrence rate of meningioma correlates with its pathological grade. High-grade malignant meningioma or WHO grade II meningioma, which is between benign and malignant, grows rapidly and is difficult to remove completely, and is prone to recurrence even after surgical resection with adjuvant radiation therapy, even within a short period of time. The recurrence of meningioma is related to the location of tumor growth and the relationship with surrounding neurovascular structures, because these factors directly affect whether the tumor can be completely excised or not. Recurrence of meningioma is also related to treatment. Failure to remove meningioma and attached dura mater during surgery, or failure to provide active adjuvant radiotherapy after surgery for high-grade meningioma, may shorten the time to recurrence. Although most meningiomas are benign, the percentage of recurrences that can be found within a relatively long follow-up period after tumor resection surgery is still quite high. Therefore, during the treatment of meningioma, we should pay attention to the extent of tumor removal and brain function protection during surgery, and reasonably use adjuvant therapy such as radiotherapy, and we must follow up regularly after surgery to detect recurring tumors early and deal with them in time.